Skip to main content
TipRanks
Go Ultimate75% OFF

Syngen Biotech Co., Ltd. (8279) Balance Sheet

Syngen Biotech Co., Ltd. Balance Sheet

Syngen Biotech Co., Ltd.'s total assets for Q3 2026 were NT$3.14B, a decrease of 0.63% from the previous quarter. TW:8279 total liabilities were NT$735.85M for the fiscal quarter, a 10.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 3.05BNT$ 3.08BNT$ 3.11BNT$ 3.07BNT$ 2.42B
NT$ 674.89MNT$ 848.52MNT$ 974.63MNT$ 1.08BNT$ 644.16M
NT$ 2.37BNT$ 2.24BNT$ 2.13BNT$ 1.99BNT$ 1.77B

Currency in TWD

Syngen Biotech Co., Ltd. Liabilities to Assets

01.2B2.4B3.6B18 %24 %30 %36 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets